Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Inspire Medical Systems Inc’s stock clocked out at $137.37, down -1.93% from its previous closing price of $140.07. In other words, the price has decreased by -$1.93 from its previous closing price. On the day, 1.97 million shares were traded. INSP stock price reached its highest trading level at $141.09 during the session, while it also had its lowest trading level at $133.8849.
Ratios:
To gain a deeper understanding of INSP’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.39. For the most recent quarter (mrq), Quick Ratio is recorded 4.01 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On December 02, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $130. Truist Upgraded its Hold to Buy on November 26, 2025, while the target price for the stock was maintained at $165.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 02 ’25 when mcCormick Shawn sold 1,200 shares for $139.00 per share. The transaction valued at 166,800 led to the insider holds 24,846 shares of the business.
SHAWN T MCCORMICK bought 1,200 shares of INSP for $151,608 on Dec 02 ’25. On Nov 28 ’25, another insider, mcCormick Shawn, who serves as the Director of the company, sold 2,000 shares for $127.48 each. As a result, the insider received 254,960 and left with 26,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 4062623744 and an Enterprise Value of 3701466368. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 94.22, and their Forward P/E ratio for the next fiscal year is 78.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.52 while its Price-to-Book (P/B) ratio in mrq is 5.99. Its current Enterprise Value per Revenue stands at 4.194 whereas that against EBITDA is 75.02.
Stock Price History:
The Beta on a monthly basis for INSP is 0.70, which has changed by -0.2686472 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $216.01, while it has fallen to a 52-week low of $70.77. The 50-Day Moving Average of the stock is 45.73%, while the 200-Day Moving Average is calculated to be 13.74%.
Shares Statistics:
It appears that INSP traded 1.31M shares on average per day over the past three months and 1682980 shares per day over the past ten days. A total of 29.05M shares are outstanding, with a floating share count of 27.78M. Insiders hold about 4.41% of the company’s shares, while institutions hold 104.45% stake in the company. Shares short for INSP as of 1764288000 were 3481719 with a Short Ratio of 2.67, compared to 1761868800 on 3305009. Therefore, it implies a Short% of Shares Outstanding of 3481719 and a Short% of Float of 16.189999999999998.
Earnings Estimates
The stock of Inspire Medical Systems Inc (INSP) is currently being evaluated by 13.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.15, with high estimates of $0.41 and low estimates of -$0.22.
Analysts are recommending an EPS of between $1.65 and $0.99 for the fiscal current year, implying an average EPS of $1.51. EPS for the following year is $1.72, with 13.0 analysts recommending between $2.45 and $1.31.
Revenue Estimates
In. The current quarter, 14 analysts expect revenue to total $262.46M. It ranges from a high estimate of $263.1M to a low estimate of $262M. As of. The current estimate, Inspire Medical Systems Inc’s year-ago sales were $239.72MFor the next quarter, 14 analysts are estimating revenue of $213.4M. There is a high estimate of $223.4M for the next quarter, whereas the lowest estimate is $204.21M.
A total of 17 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $908.29M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $905.04M. In the same quarter a year ago, actual revenue was $802.8MBased on 17 analysts’ estimates, the company’s revenue will be $1B in the next fiscal year. The high estimate is $1.01B and the low estimate is $996.47M.
